Merlin Capital LLC Tilray Brands, Inc. Transaction History

Merlin Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$1.52 - $2.78 $910,752 - $1.67 Million	599,179 New	599,179 $1.87 Million
Q4 2022 Feb 13, 2023	SELL	$2.58 - $4.68 $559,302 - $1.01 Million	-216,784 Reduced 35.33%	396,814 $1.07 Million
Q3 2022 Nov 14, 2022	BUY	$2.7 - $4.3 $38,931 - $62,001	14,419 Added 2.41%	613,598 $1.69 Million
Q2 2022 Jul 20, 2022	BUY	$3.11 - $7.48 $316,902 - $762,197	101,898 Added 20.49%	599,179 $1.87 Million
Q1 2022 May 16, 2022	BUY	$4.88 - $8.56 $296,347 - $519,823	60,727 Added 13.91%	497,281 $3.86 Million
Q4 2021 Mar 14, 2022	BUY	$7.03 - $13.03 $3.07 Million - $5.69 Million	436,554 New	436,554 $3.07 Million

403

99.9M

8.59M

8.9M

Ticker TLRY
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 611,401,984
Market Cap $807M
Description
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...

Get notified when there are updates to the investment portfolio of Merlin Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Merlin Capital LLC with notifications on news.